Dr Reddy's Laboratories (Dr Reddy's Laboratories) Total Assets

: $4,478 Mil (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

Dr Reddy's Laboratories's Total Assets for the quarter that ended in Dec. 2023 was $4,478 Mil.

During the past 12 months, Dr Reddy's Laboratories's average Total Assets Growth Rate was 15.20% per year. During the past 3 years, the average Total Assets Growth Rate was 8.00% per year. During the past 5 years, the average Total Assets Growth Rate was 5.70% per year. During the past 10 years, the average Total Assets Growth Rate was 7.40% per year.

During the past 13 years, Dr Reddy's Laboratories's highest 3-Year average Total Assets Growth Rate was 60.50%. The lowest was 0.80%. And the median was 10.70%.

Total Assets is connected with ROA %. Dr Reddy's Laboratories's annualized ROA % for the quarter that ended in Dec. 2023 was 15.31%. Total Assets is also linked to Revenue through Asset Turnover. Dr Reddy's Laboratories's Asset Turnover for the quarter that ended in Dec. 2023 was 0.20.

Dr Reddy's Laboratories Total Assets Historical Data

The historical data trend for Dr Reddy's Laboratories's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Assets

3,244.04

3,115.31

3,645.87

3,843.40

3,912.33

Dr Reddy's Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets																3,750.28	3,912.33	4,074.68	4,177.47	4,478.37

Dr Reddy's Laboratories Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Dr Reddy's Laboratories's Total Assets for the fiscal year that ended in Mar. 2023 is calculated as

Total Assets	=	Total Equity (A: Mar. 2023 )	+	Total Liabilities (A: Mar. 2023 )
	=	2807.838	+	1104.496
	=	3,912

Dr Reddy's Laboratories's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	3217.263	+	1261.105
	=	4,478

Dr Reddy's Laboratories (NYSE:RDY) Total Assets Explanation

Total Assets is connected with ROA %.

Dr Reddy's Laboratories's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	662.504	/	( (4177.465	+	4478.367)	/ 2 )
	=	662.504	/	4327.916
	=	15.31 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Dr Reddy's Laboratories's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	866.601	/	( (4177.465	+	4478.367)	/ 2 )
=	866.601	/	4327.916
=	0.20

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Dr Reddy's Laboratories Total Assets Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories (Dr Reddy's Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NYSE:RDY) » Definitions » Total Assets

Traded in Other Exchanges

DRREDDY:India 500124:India RDDA:Germany RDDA:Germany R1DY34:Brazil

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.